Olene is an innovation driven company that currently has 13 industry leading patents including 4 (four) platform technologies for application in Human and Animal nutrition. Olene’s patented platform technology, Aqueosome®, delivers highly concentrated, highly bioavailable and sustained release phytochemicals for long lasting and higher therapeutic benefits. Our Patented Ginger product, GinfortTM, contains the highest concentration of Gingeroids thereby reducing the dose without compromising the therapeutic benefits. Through another platform technology, Self-D®, Olene has developed the world’s highest concentrated Curcumin product, Curcugen™, in a self-dispersible form. In a human clinical study, CurcugenTM showed 39x more bioavailability for free curcumin. We also have the world’s highest SAC content garlic product, GarlzacTM (0.24% to 8% SAC content) in powder form as well as a product developed specifically for Premature Ejaculation, Synura® (Fortiquin™). In a human clinical study, Synura® increased IELT (Inter Ejaculatory Latency Time) by 5.1x. Due to its disruptive innovation technologies, US based Dolcas Biotech has partnered with Olene to market their Curcugen™ and Fortiquin™ products. In the animal sector, Nitrigen®, a patented Slow Release non protein nitrogen product developed by Olene is one of the world’s best non protein nitrogen source for Ruminants. This product has been licensed to a Spanish company for manufacturing and sale in Europe and LatAm.